I. Introduction
===============

Phosphatidylinositol 3,4-bisphosphate \[PtdIns(3,4)P~2~\] is a phosphoinositide of minor abundance \[[@B19]\]. It was previously assumed to be an intermediate product of PtdIns(3,4,5)P~3~ degradation, with no particular significance on its own. However, the presence of phosphatases dedicated to the hydrolysis of PtdIns(3,4)P~2~ (i.e., inositol polyphosphate 4-phosphatases \[INPP4A and INPP4B\]) \[[@B3], [@B25]\] and proteins specifically binding to PtdIns(3,4)P~2~, such as the tandem PH domain-containing proteins (TAPP1 and TAPP2) \[[@B16], [@B21]\] and lamellipodin/RAPH1 \[[@B18]\], indicated that PtdIns(3,4)P~2~ has its own functions. Moreover, PtdIns(3,4)P~2~ binds to PtdIns(3,4,5)P~3~ effectors, including Akt \[[@B7]\] and 3-phosphoinositide-dependent protein kinase PDK1 \[[@B1]\], with an affinity comparable to PtdIns(3,4,5)P~3~. By doing so, it may modulate the PtdIns(3,4,5)P~3~-related functionalities of these proteins. Mainly through analyses of the above-mentioned proteins, it is now recognized that PtdIns(3,4)P~2~ is involved in a wide range of cellular phenomena, from signal transduction to endocytosis and cell migration \[[@B20]\].

The physiological importance of PtdIns(3,4)P~2~ being revealed, the need to determine where and how PtdIns(3,4)P~2~ is located in the cell is more urgent than ever. Although methods to quantify the amount of PtdIns(3,4)P~2~ in isolated samples have been developed \[[@B26]\], considering the quick time course over which PtdIns(3,4)P~2~ is thought to be generated and hydrolyzed, microscopic methods to observe its distribution are essential for understanding PtdIns(3,4)P~2~ functions more in detail. In this context, the GFP (or YFP)-tagged pleckstrin homology (PH) domain of TAPP1 was used for live imaging \[[@B16], [@B21]\], and recombinant TAPP1-PH and anti-PtdIns(3,4)P~2~ antibody were used for labeling fixed cells and tissues \[[@B5], [@B15], [@B31]\]. Although the results obtained by these methods gave insights into the function of PtdIns(3,4)P~2~, the innate problems of those methods have been pointed out \[[@B2], [@B27]\].

In the present study, we aimed to establish a method to observe the distribution of PtdIns(3,4)P~2~ by the quick-freezing and freeze-fracture replica labeling (QF-FRL) technique \[[@B9], [@B11]\]. In this method, lipids are physically immobilized by freezing followed by freeze-fracture replica formation, and are then labeled for electron microscopic observation. We found that GST-tagged TAPP1-PH labels PtdIns(3,4)P~2~ with a higher specificity than a commercially available anti-PtdIns(3,4)P~2~ antibody in freeze-fracture replicas. The QF-FRL method using GST-tagged TAPP1-PH as the probe is expected to be useful in delineating the fine distribution of PtdIns(3,4)P~2~ in various settings.

II. Materials and Methods
=========================

Liposomes
---------

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (PC) (Nichiyu, Tokyo, Japan) and synthetic dipalmitoylated phosphoinositides (CellSignals, Columbus, OH) were used to prepare liposomes. The lipids were dried in nitrogen gas, hydrated in 20 mM Hepes-NaOH (pH 7.4), and mixed by vortexing. To make unilamellar liposomes, the lipid suspension was passed through a polycarbonate membrane filter with 0.2 μm pores using a Mini-Extruder (Avanti Polar Lipids, Alabaster, AL).

Cell culture
------------

Mouse NIH3T3 cells were maintained in Dulbecco's modified Eagle's medium with high glucose (Sigma-Aldrich, St. Louis, MO) supplemented with 10% (v/v) fetal bovine serum (FBS; Nichirei, Tokyo, Japan) at 37°C in a humidified atmosphere of 95% air and 5% CO~2~. For expression of fluorescent biosensors, cells were transfected with cDNA using jetPRIME transfection reagent (Polyplus-transfection, New York, NY) following the manufacturer's instruction. The cells were serum-starved for 16 hr in a medium containing 0.5% FBS before being treated with either 10 mM H~2~O~2~ or 5 ng/ml recombinant mouse platelet-derived growth factor (PDGF-BB; ProSpec, East Brunswick, NJ).

Probes
------

The PH domain of TAPP1 (amino acids 182--303) was amplified from HeLa cell cDNA using a forward primer (5\'-CGGGATCCTTTTACTCCTAAACCACCTAA-3\') and a reverse primer (5\'-GGAATTCTCAGGGATGCTCAGAA GACGCAGA-3\'), digested with BamHI and EcoRI, and integrated to the pGEX-6P-1 plasmid (GE Healthcare). The mutant probe TAPP1(R211L), in which binding with PtdIns(3,4)P~2~ is abrogated by replacement of the 211st arginine of TAPP1 to leucine \[[@B6]\], was generated by polymerase chain reaction using the following primer sets: 5\'-GGAGCAGTGATGAAAAACTGGAAGAGA[CT]{.ul}ATATTTTCAATTGG-3\' and 5\'-CCAATTGAAAATAT[AG]{.ul}TCTCTTCCAGTTTTTCATCACTGCTCC-3\'. GST-tagged recombinant proteins expressed in BL21 *Escherichia coli* cells were purified using glutathione-agarose (Sigma-Aldrich) and dialyzed to phosphate-buffered saline (PBS).

Quick freezing and freeze-fracture replica preparation
------------------------------------------------------

Quick freezing and freeze-fracture replica formation were carried out as described previously \[[@B4]\]. In brief, samples sandwiched between a thin copper foil (20 μm) and a flat aluminum disc (Engineering Office M. Wohlwend, Sennwald, Switzerland) were frozen using an HPM 010 high-pressure freezing machine (Leica Microsystems, Wetzler, Germany), and freeze-fracture replicas were prepared in a BAF400 apparatus (BAL-TEC) by electron-beam evaporation in three steps: carbon (2--5 nm in thickness) at an angle of 90° to the specimen surface, platinum-carbon (1--2 nm) at an angle of 45°, and carbon (10--20 nm) at an angle of 90°. Thawed freeze-fracture replicas were treated with 2.5% SDS in 0.1 M Tris-HCl (pH 7.4) at 60°C overnight.

Freeze-fracture replica labeling
--------------------------------

Freeze-fracture replicas were washed five times with PBS containing 0.1% Triton X-100 (PBST), blocked with 3% fatty acid-free bovine serum albumin (BSA) and 2% cold fish gelatin (CFG) in PBS for 30 min at room temperature, washed once in PBST, and incubated at 4°C overnight with GST-TAPP1 or GST-TAPP1(R211L) at the concentration of 10 ng/ml in PBS with 1% BSA and 0.67% CFG. The samples were washed five times with PBST, treated with rabbit anti-GST antibody (10 μg/ml; Bethyl Laboratories, Montgomery, TX) in PBS with 1% BSA and 0.67% CFG for 30 min at 37°C, washed five times with PBST, and incubated with protein A conjugated with 5 nm or 10 nm colloidal gold (PAG5, PAG10) (1:50 or 1:60 dilution of the supplied solution; The University Medical Center Utrecht, Utrecht, The Netherlands) in PBS with 1% BSA and 0.67% CFG for 30 min at 37°C. In some experiments, mouse anti-PtdIns(3,4)P~2~ antibody (10 μg/ml; Echelon, Salt Lake City, UT) was used instead of GST-TAPP1. After being washed five times with PBST, the replicas were rinsed with distilled water, picked up on Formvar-coated electron microscopy (EM) grids, and observed with a JEOL JEM-1011EM (Tokyo, Japan) operated at 100 kV. Digital images were captured using a charge-coupled device camera (Gatan, Pleasanton, CA).

Quantitative analysis
---------------------

The number of colloidal gold particles in EM images was counted manually, and areas were measured using Image J (NIH). The labeling density in the selected structure was calculated by dividing the number of colloidal gold particles by the area. For each structure, the labeling density was measured in ten different micrographs that were taken randomly. Every experiment was repeated more than two times, and a representative result is shown.

III. Results
============

GST-TAPP1-PH binds to PtdIns(3,4)P~2~ in freeze-fracture replicas
-----------------------------------------------------------------

In QF-FRL, freeze-fracture replicas physically fix a membrane leaflet, and phospholipids and sphingolipids held in the replicas are labeled with various probes \[[@B4], [@B10], [@B11], [@B23], [@B28]\]. In applying QF-FRL to a new lipid molecule, it is critical to select an appropriate binding probe, because a probe binding to the target lipid specifically in another modality (e.g., dot blot) does not necessarily bind to the same lipid with a similar specificity in QF-FRL. This is not a problem with QF-FRL alone; similar divergence was also noticed between other methods using lipid-binding probes \[[@B24]\].

In selecting appropriate probes, QF-FRL has an advantage because the binding specificity of probes can be tested without resorting to other methods. That is, whether a probe specifically binds to the target lipid or not can be examined by applying it to freeze-fracture replicas of liposomes with different compositions. In the present study, we prepared liposomes containing 95 mol% phosphatidylcholine (PC) and 5 mol% of a phosphoinositide, and subjected their freeze-fracture replicas to labeling with two probes: one was recombinant GST-tagged TAPP1-PH \[[@B31]\] and the other was mouse anti-PtdIns(3,4)P~2~ antibody \[[@B5]\].

By measuring the density of colloidal gold labels in freeze-fracture replicas of liposomes, we found that GST-TAPP1-PH binds to PtdIns(3,4)P~2~ with by far the highest intensity ([Fig. 1](#F1){ref-type="fig"}A, B). It also showed binding to PtdIns(3,4,5)P~3~, but the labeling intensity to PtdIns(3,4,5)P~3~ was much lower than that to PtdIns(3,4)P~2~. In contrast, the mouse anti-PtdIns(3,4)P~2~ antibody bound to phosphatidylinositol and several phosphoinositides other than PtdIns(3,4)P~2~ with significant intensities ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). It was particularly worrisome that the antibody bound to PtdIns(4,5)P~2~ and phosphatidylinositol with high intensities, because the cellular content of those two lipids are much higher than that of PtdIns(3,4)P~2~ \[[@B19]\]. We thus used GST-TAPP1-PH as the probe to label PtdIns(3,4)P~2~ in subsequent studies.

As the second line of evidence to show the binding specificity of GST-TAPP1-PH, we used a one amino acid-substituted mutant of TAPP1, R211L, that is deficient in binding to PtdIns(3,4)P~2~ \[[@B6]\]. It was confirmed that GST-TAPP1-PH(R211L) does not bind to the freeze-fracture replica of PtdIns(3,4)P~2~-containing liposomes ([Fig. 1](#F1){ref-type="fig"}C). The result indicated that GST-TAPP1-PH binds to PtdIns(3,4)P~2~ in freeze-fracture replicas in the same manner as it does to PtdIns(3,4)P~2~ in cells. The mutant probe, GST-TAPP1-PH(R211L) is useful as a negative control to exclude non-specific binding in cellular samples, in which proteins as well as non-tested lipids might show affinity to GST-TAPP1-PH.

Treatment with H~2~O~2~ and PDGF increases PtdIns(3,4)P~2~ in the plasma membrane
---------------------------------------------------------------------------------

PtdIns(3,4)P~2~ in culture cells was shown to increase significantly upon treatment with H~2~O~2~ \[[@B30]\] and PDGF \[[@B13]\]. These results were confirmed by live imaging using YFP-TAPP1-PH \[[@B16]\] and by immunoelectron microscopy using recombinant GST-TAPP1-PH \[[@B31]\]. The same studies also showed that PtdIns(3,4)P~2~ increases in the plasma membrane upon stimulation \[[@B16], [@B31]\]. Additionally, the immunoelectron microscopic study suggested an increase of PtdIns(3,4)P~2~ in the endoplasmic reticulum (ER) and the internal vesicles of the multivesicular body \[[@B31]\].

We confirmed that H~2~O~2~ and PDGF increased PtdIns(3,4)P~2~ in the plasma membrane of NIH3T3 cells by observing the distribution of expressed GFP-TAPP1-PH by fluorescence microscopy (data not shown). In this cell type, the obvious distributional change of GFP-TAPP1-PH (i.e., from diffuse cytosolic to cell periphery) with H~2~O~2~ occurred only when it was used at 10 mM. Therefore, NIH3T3 cells treated with 10 mM H~2~O~2~ for 10 min and those treated with 5 ng/ml PDGF for 10 min were examined in subsequent experiments.

When NIH3T3 cells were quick-frozen without applying any reagent, the labeling for PtdIns(3,4)P~2~ in the freeze-fracture replica was scarce either in the plasma membrane or in any other cellular membranes ([Fig. 2](#F2){ref-type="fig"}A, left). After stimulation with H~2~O~2~ for 10 min, intense labeling was observed in the cytoplasmic leaflet of the plasma membrane ([Fig. 2](#F2){ref-type="fig"}A, right). Treatment with PDGF for 10 min also increased the PtdIns(3,4)P~2~ labeling in the cytoplasmic leaflet of the plasma membrane ([Fig. 2](#F2){ref-type="fig"}B). Although variation among cells was observed in both experiments, the average labeling density in the plasma membrane increased approximately 45-fold and 18-fold after the treatment with H~2~O~2~ and PDGF, respectively ([Fig. 2](#F2){ref-type="fig"}C).

The PtdIns(3,4)P~2~ labeling in the plasma membrane of cells after treatment with H~2~O~2~ or PDGF was distributed without prominent local variation. It is of note, however, that the labeling largely spared the membrane of shallow caveolae, whereas a small population of deep caveolae showed dense labeling at their orifice ([Fig. 2](#F2){ref-type="fig"}D). The shallow and deep caveolae can be identified by morphology alone, but their identity was further confirmed by immunolabeling for caveolin-1 ([Supplementary Fig. 2](#SD2){ref-type="supplementary-material"}) \[[@B8]\]. This distribution pattern of PtdIns(3,4)P~2~ labeling was different from that of phosphatidylinositol 4,5-bisphosphate, which shows concentration in both deep and shallow caveolae \[[@B11]\]. Binding of cavins is thought to stabilize deep caveolae invagination \[[@B17]\], but it is not clear whether generation of deep and shallow caveolae is dictated solely by cavins. It would be interesting to study if phosphatidylinositols play any role in the definition of caveolae depth.

Importantly, the mutant probe, GST-TAPP1-PH(R211L), did not show labeling in either unstimulated or stimulated cellular samples ([Fig. 2](#F2){ref-type="fig"}C, [Supplementary Fig. 3](#SD3){ref-type="supplementary-material"}), indicating that the label obtained with GST-TAPP1-PH was derived from PtdIns(3,4)P~2~, and not caused by nonspecific binding.

We also observed intracellular membranes of the stimulated cells by QF-FRL. In H~2~O~2~-treated cells, the inner and outer mitochondrial membranes were devoid of PtdIns(3,4)P~2~ labeling ([Fig. 3](#F3){ref-type="fig"}A) whereas membranes in the Golgi occasionally showed a low level of labeling ([Fig. 3](#F3){ref-type="fig"}B). Additionally, some vesicular structures were labeled in the cytoplasmic leaflet ([Fig. 3](#F3){ref-type="fig"}C), but the identity of those structures could not be determined by morphological criteria. In view of the previous report that showed an increase of PtdIns(3,4)P~2~ in the ER membrane after the H~2~O~2~ treatment \[[@B31]\], they might represent the ER membrane. Cells after the PDGF treatment gave similar results (data not shown).

IV. Discussion
==============

The present study showed that QF-FRL can label PtdIns(3,4)P~2~ using recombinant GST-TAPP1-PH as the probe. In comparison to EM methods using ultrathin sections, an advantage of freeze-fracture EM is that membranes can be observed in two-dimensional planes. Because the method can visualize PtdIns(3,4)P~2~ distribution in a high spatial resolution, it is expected to be useful to analyze phenomena occurring in small areas of membranes.

Additionally, the QF-FRL method appears to label PtdIns(3,4)P~2~ more efficiently than the method using sections: the increase of PtdIns(3,4)P~2~ labeling after stimulation with H~2~O~2~ and PDGF was approximately 45-fold and 18-fold (per unit area of the plasma membrane), respectively, by QF-FRL, whereas by methods using sections, the increase (per unit length of the plasma membrane) was approximately four-fold and 2- to 2.5-fold when PtdIns(3,4)P~2~ was directly labeled \[[@B31]\] and approximately 10.4-fold and 5.2-fold when expressed GFP-TAPP1-PH was labeled \[[@B16]\]. The result of QF-FRL agrees better with the drastic increase of PtdIns(3,4)P~2~ that was measured biochemically \[[@B13], [@B30]\].

Efficient labeling, or a high capture ratio, of QF-FRL was also noticed in the labeling of other membrane lipids \[[@B4], [@B10], [@B11]\]. One of the reasons for this efficiency is that freeze-fracture replicas can hold membrane lipids physically \[[@B12]\]. Despite the extensive SDS treatment, a model study using liposomes showed that no less than 80% of phospholipids are retained in the replica \[[@B12]\]. In contrast, chemical fixation using aldehydes does not work on most lipids \[[@B29]\] so redistribution of lipids may occur even after fixation \[[@B4], [@B14], [@B22]\]. We argue that physical fixation provided by freeze-fracture replicas is crucial for retaining membrane lipids for various analyses \[[@B27]\].

On the other hand, freeze-fracture EM has several problems. One is the difficulty in identifying some subcellular structures, as exemplified by the ER membrane in the present study. Another is the difficulty of observing long protrusions and deep indentations in their entirety because the fracture plane tends to run horizontally, that is, along flat membranes \[[@B9]\]. Furthermore, it is not clear whether the retention of lipids occurs with the same efficiency in membranes of different curvatures, and steric hindrance between probes poses a problem when the labeling density is high \[[@B27]\]. More specifically, on the present method, it needs to be reminded that a non-negligible level of binding may occur with PtdIns(3,4,5)P~3~. Despite these problems, however, we believe that the method using TAPP1-PH for freeze-fracture replica labeling is an important tool that can be employed to analyze PtdIns(3,4)P~2~ in various cellular context.
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![Labeling of liposomes with GST-TAPP1-PH. **A.** Freeze-fracture replicas of liposomes containing 5 mol% of a phosphoinositide or phosphatidylinositol (PI) and 95 mol% of phosphatidylcholine were labeled with GST-TAPP1-PH. Liposomes containing PtdIns(3,4)P~2~ showed by far the most intense labeling. 10 nm gold particles were used. **B.** Quantification of GST-TAPP1-PH labels in the liposome replicas. More than 100 liposomes were randomly chosen and the number of gold particles and the surface area were measured. Mean ± standard error of the mean (SEM) of three independent experiments. **C.** Freeze-fracture replicas of the liposome containing PtdIns(3,4)P~2~ were incubated with either 10 ng/ml GST-TAPP1-PH or 10 ng/ml GST-TAPP1-PH(R211L). The labeling was observed only in samples incubated with GST-TAPP1-PH. 10 nm gold particles were used.](AHC17025f01){#F1}

![Labeling of PtdIns(3,4)P~2~ in the plasma membrane of NIH3T3 cells. **A.** Labeling of PtdIns(3,4)P~2~ in NIH3T3 cells using GST-TAPP1-PH. Cells were either untreated (left) or treated with 10 mM H~2~O~2~ for 10 min (right). Freeze-fracture replicas of the cytoplasmic leaflet of the plasma membrane are shown. Colloidal gold labels (5 nm) are observed much more densely in H~2~O~2~-treated samples than in the untreated control, and distribute in the membrane without conspicuous local concentration. **B.** Labeling of PtdIns(3,4)P~2~ in NIH3T3 cells that were treated with 5 ng/ml PDGF for 10 min. Significant labeling was observed in the cytoplasmic leaflet of the plasma membrane. 5 nm gold particles were used. **C.** Quantification of PtdIns(3,4)P~2~ labels (5 nm gold particles) in the NIH3T3 cell replicas. The freeze-fracture replicas of cells, either untreated, treated with 10 mM H~2~O~2~ for 10 min, or treated with 5 ng/ml PDGF for 10 min, were incubated with GST-TAPP1-PH or GST-TAPP1-PH(R211L). Ten different areas were randomly chosen, and the number of gold particles per unit membrane area was quantified. Mean ± SEM of one representative experiment is shown. The labeling with GST-TAPP1-PH (shown as WT) increased significantly after the treatment with H~2~O~2~ or PDGF, whereas that with GST-TAPP1-PH(R211L) was negligible. **D.** Caveolae in NIH3T3 cells treated with 10 mM H~2~O~2~ for 10 min. The PtdIns(3,4)P~2~ label (10 nm gold particles) was not present in the indented area of shallow caveolae (arrows); note that the bottom of deep caveolae could not be seen due to fracturing at their neck (arrowheads and dotted circles). The majority of caveolae did not exhibit particular concentration of the label around them (arrows and arrowheads), whereas some deep caveolae exhibited a denser labeling at the orifice (dotted circles).](AHC17025f02){#F2}

![Labeling of PtdIns(3,4)P~2~ in the intracellular organelles of NIH3T3 cells. Labeling of PtdIns(3,4)P~2~ in NIH3T3 cells treated with 10 mM H~2~O~2~ for 10 min. 10 nm gold particles were used. **A.** Mitochondrial membranes. Four membrane leaflets, i.e., the cytoplasmic and non-cytoplasmic leaflets of the outer (OM) and inner (IM) membranes, can be identified in this picture. They were all devoid of labeling. P and E faces correspond to the cytoplasmic and non-cytoplasmic leaflets of the membranes, respectively. **B.** The Golgi membranes. A small number of labels (arrows) were observed in the cytoplasmic leaflet of some membranes. **C.** Some intracellular membranes, which might be the ER, exhibited labeling in the cytoplasmic leaflet (arrows).](AHC17025f03){#F3}
